Top Markets
#1 Islamic Coin Islamic Coin +151.50%
#2 Akedo Akedo +48.58%
#3 DOVU DOVU +47.59%
#4 Velvet Velvet +38.22%
#5 Black Phoenix Black Phoenix +34.27%
#6 Cross Cross +19.42%
#7 DoubleZero DoubleZero +17.37%
#8 Cap Cap +16.79%
#9 Tutorial Tutorial +15.74%
#10 Not in Employment, Education, or Training Not in Employment, Education, or Training +9.89%
Coin of the day
Islamic Coin Islamic Coin
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Galera Therapeutics, Inc. Galera Therapeutics, Inc.

Galera Therapeutics, Inc.

GRTX
Classifica tra le azioni #33956
Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical... Galera Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, specializing in the creation and commercialization of therapies aimed at revolutionizing cancer radiotherapy. Its lead investigational drug, avasopasem manganese (GC4419), functions as a small molecule superoxide dismutase mimetic. This compound has successfully completed a Phase III clinical trial targeting severe oral mucositis induced by radiation therapy in head and neck cancer (HNC) patients. Furthermore, GC4419 is currently undergoing Phase IIa clinical trials for radiotherapy-induced esophagitis in lung cancer patients, as well as for HNC patients undergoing standard-of-care radiation treatment. The company is also progressing with GC4711, another superoxide dismutase mimetic candidate, which is in a Phase I/II clinical trial. This trial evaluates its combination with stereotactic body radiation therapy (SBRT) for individuals diagnosed with non-small cell lung cancer and locally advanced pancreatic cancer. Galera Therapeutics was founded in 2012 and maintains its headquarters in Malvern, Pennsylvania.
Prezzo delle azioni
$17.15
Ultima sincronizzazione: 2026-08-03
Capitalizzazione di mercato
$6.51M
Variazione (1 giorno)
9.80%
Variazione (1 anno)
289.77%
Paese
US
Scambia Galera Therapeutics, Inc. (GRTX)

Categoria

Healthcare
EPS per Galera Therapeutics, Inc. (GRTX)
EPS al March 2026 TTM: $303.74
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Galera Therapeutics, Inc., l’EPS attuale della società (TTM) è $303.74. Alla fine del 2023, la società aveva un EPS di $-1.33 una diminuzione rispetto a rispetto a quello del 2022, che era di $-2.30.
Storico EPS per Galera Therapeutics, Inc. da 2017 a 2026
EPS alla fine di ogni anno
Anno EPS Cambia
2026 (TTM) $303.74 -86,882.86%
2024 $-0.35 -73.68%
2023 $-1.33 -42.17%
2022 $-2.30 -32.35%
2021 $-3.40 14.09%
2020 $-2.98 42.58%
2019 $-2.09 71.31%
2018 $-1.22 7,770.97%
2017 $-0.02 0.00%
EPS per aziende simili o concorrenti
Azienda EPS Differenza di EPS Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -94.30%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -90.87%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -95.49%
BE